|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging growth company
|
|
Page
|
||
|
1
|
||
|
PART I
|
||
|
Item 1.
|
2
|
|
|
2
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
5
|
||
|
7
|
||
|
7
|
||
|
8
|
||
| 8 |
||
| 9 |
||
|
9
|
||
|
9
|
||
|
10
|
||
|
11
|
||
|
11
|
||
|
11
|
||
|
|
||
|
Item 1A.
|
11
|
|
|
Item 1B.
|
11
|
|
|
Item 1C.
|
12
|
|
|
Item 2.
|
13
|
|
|
Item 3.
|
13 | |
|
Item 4.
|
13 | |
|
|
||
|
PART II
|
|
|
|
Item 5.
|
14 | |
|
Item 6.
|
14 | |
|
Item 7.
|
15 | |
|
Item 7A.
|
22 | |
|
Item 8.
|
23
|
|
|
Item 9.
|
58
|
|
|
Item 9A.
|
58
|
|
|
Item 9B.
|
59
|
|
|
Item 9C.
|
59
|
|
|
|
||
|
PART III
|
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
60 |
|
Item 11.
|
Executive Compensation
|
60 |
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
|
60 |
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
60 |
|
Item 14.
|
Principal Accountant Fees and Services
|
60 |
|
|
||
|
PART IV
|
|
|
|
Item 15.
|
61 |
|
|
Item 16.
|
62
|
|
|
63
|
||
| 64 | ||
| 67 | ||
| 69 |
||
| 70 |
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Automobile liability
|
$
|
39,788
|
$
|
38,821
|
||||
|
Automobile physical damage
|
13,464
|
15,046
|
||||||
|
General liability
|
5,990
|
5,758
|
||||||
|
Surety
|
5,809
|
6,303
|
||||||
|
Other lines
|
2,638
|
2,515
|
||||||
|
Total
|
$
|
67,689
|
$
|
68,443
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Group life
|
$
|
14,700
|
$
|
12,431
|
||||
|
Individual life
|
5,594
|
6,153
|
||||||
|
Total life
|
20,294
|
18,584
|
||||||
|
Medicare supplement
|
71,867
|
77,424
|
||||||
|
Group accident and health
|
11,390
|
7,583
|
||||||
|
Other individual health
|
7,491
|
6,791
|
||||||
|
Total health
|
90,748
|
91,798
|
||||||
|
Total
|
$
|
111,042
|
$
|
110,382
|
||||
|
December 31,
|
||||||||||||||||
|
2024
|
2023
|
|||||||||||||||
|
Amount
|
Percent
|
Amount
|
Percent
|
|||||||||||||
|
(Dollars in thousands)
|
||||||||||||||||
|
Fixed maturities:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
22,251
|
9.7
|
%
|
$
|
22,849
|
9.6
|
%
|
||||||||
|
Loan backed and structured securities
|
22,290
|
9.7
|
27,210
|
11.5
|
||||||||||||
|
States, municipalities and political subdivisions
|
7,623
|
3.3
|
8,106
|
3.4
|
||||||||||||
|
All other corporate bonds
|
160,261
|
69.6
|
159,849
|
67.4
|
||||||||||||
|
Redeemable preferred stock
|
187
|
0.1
|
205
|
0.1
|
||||||||||||
|
Total fixed maturities(1)
|
212,612
|
92.4
|
218,219
|
92.0
|
||||||||||||
|
Equity securities(2)
|
7,900
|
3.4
|
9,413
|
4.0
|
||||||||||||
|
Other invested assets(3)
|
6,616
|
3.0
|
6,381
|
2.8
|
||||||||||||
|
Policy loans(4)
|
1,722
|
0.7
|
1,778
|
0.7
|
||||||||||||
|
Real estate
|
38
|
0.0
|
38
|
0.0
|
||||||||||||
|
Investments in unconsolidated trusts
|
1,238
|
0.5
|
1,238
|
0.5
|
||||||||||||
|
Total investments
|
$
|
230,126
|
100.0
|
%
|
$
|
237,067
|
100.0
|
%
|
||||||||
| (1) |
Fixed maturities are carried on the balance sheet at estimated fair value. Certain fixed maturities do not have publicly quoted prices, and are carried at estimated fair value as determined by management.
Total amortized cost of fixed maturities was $236.3 million as of December 31, 2024 and $238.6 million as of December 31, 2023.
|
| (2) |
Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $4.9 million as of December 31, 2024 and 2023.
|
| (3) |
Other invested assets are accounted for using the equity method. Total cost of other invested assets was $7.9 million as of December 31, 2024 and $7.0 million as of December 31, 2023.
|
| (4) |
Policy loans are valued at unpaid principal balances.
|
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Average investments(1)
|
$
|
280,420
|
$
|
275,995
|
||||
|
Net investment income
|
9,791
|
10,058
|
||||||
|
Average yield on investments
|
3.5
|
%
|
3.6
|
%
|
||||
|
Realized investment gains, net
|
1,210
|
70
|
||||||
| (1) |
Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.
|
|
Name
|
Age
|
Positions with the Company
|
Director or Officer Since
|
|||
|
Hilton H. Howell, Jr.
|
62
|
Chairman of the Board, President & CEO
|
1992
|
|||
|
J. Ross Franklin
|
47
|
Vice President, CFO and Corporate Secretary
|
2017
|
| Item 1A. |
Risk Factors
|
| Item 2. |
Properties
|
| Item 3. |
Legal Proceedings
|
| Item 4. |
Mine Safety Disclosures
|
| Item 5. |
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
|
Period
|
Total
Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total
Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
|
Maximum
Number of Shares
that May Yet be
Purchased Under the
Plans or Programs
|
||||||||||||
|
October 1 – October 31, 2024
|
—
|
$
|
—
|
—
|
325,129
|
|||||||||||
|
November 1 – November 30, 2024
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
December 1 – December 31, 2024
|
—
|
—
|
—
|
325,129
|
||||||||||||
|
Total
|
—
|
$
|
—
|
—
|
||||||||||||
| Item 6. |
Reserved
|
| Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Revenue
|
||||||||
|
Property and Casualty:
|
||||||||
|
American Southern
|
$
|
72,220
|
$
|
72,846
|
||||
|
Life and Health:
|
||||||||
|
Bankers Fidelity
|
116,097
|
114,199
|
||||||
|
Corporate and Other
|
(90
|
)
|
(252
|
)
|
||||
|
Total revenue
|
$
|
188,227
|
$
|
186,793
|
||||
|
Income (loss) before income taxes
|
||||||||
|
Property and Casualty:
|
||||||||
|
American Southern
|
$
|
888
|
$
|
5,085
|
||||
|
Life and Health:
|
||||||||
|
Bankers Fidelity
|
4,155
|
4,722
|
||||||
|
Corporate and Other
|
(10,307
|
)
|
(10,372
|
)
|
||||
|
Loss before income taxes
|
$
|
(5,264
|
)
|
$
|
(565
|
)
|
||
|
Net loss
|
$
|
(4,268
|
)
|
$
|
(171
|
)
|
||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Reconciliation of Non-GAAP Financial Measure
|
||||||||
|
Net loss
|
$
|
(4,268
|
)
|
$
|
(171
|
)
|
||
|
Income tax benefit
|
(996
|
)
|
(394
|
)
|
||||
|
Realized investment gains, net
|
(1,210
|
)
|
(70
|
)
|
||||
|
Unrealized losses on equity securities, net
|
1,516
|
2,177
|
||||||
|
Non-GAAP operating income (loss)
|
$
|
(4,958
|
)
|
$
|
1,542
|
|||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Gross written premiums
|
$
|
73,671
|
$
|
77,567
|
||||
|
Ceded premiums
|
(5,979
|
)
|
(5,902
|
)
|
||||
|
Net written premiums
|
$
|
67,692
|
$
|
71,665
|
||||
|
Net earned premiums
|
$
|
67,689
|
$
|
68,443
|
||||
|
Insurance benefits and losses incurred
|
55,767
|
51,015
|
||||||
|
Commissions and underwriting expenses
|
15,565
|
16,746
|
||||||
|
Underwriting income (loss)
|
$
|
(3,643
|
)
|
$
|
682
|
|||
|
Loss ratio
|
82.4
|
%
|
74.5
|
%
|
||||
|
Expense ratio
|
23.0
|
24.5
|
||||||
|
Combined ratio
|
105.4
|
%
|
99.0
|
%
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Automobile liability
|
$
|
39,788
|
$
|
38,821
|
||||
|
Automobile physical damage
|
13,464
|
15,046
|
||||||
|
General liability
|
5,990
|
5,758
|
||||||
|
Surety
|
5,809
|
6,303
|
||||||
|
Other lines
|
2,638
|
2,515
|
||||||
|
Total
|
$
|
67,689
|
$
|
68,443
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Gross earned premiums
|
$
|
164,291
|
$
|
166,375
|
||||
|
Ceded premiums
|
(53,249
|
)
|
(55,993
|
)
|
||||
|
Net earned premiums
|
111,042
|
110,382
|
||||||
|
Insurance benefits and losses incurred
|
70,064
|
71,485
|
||||||
|
Commissions and underwriting expenses
|
41,878
|
37,992
|
||||||
|
Total expenses
|
111,942
|
109,477
|
||||||
|
Underwriting income
|
$
|
(900
|
)
|
$
|
905
|
|||
|
Loss ratio
|
63.1
|
%
|
64.8
|
%
|
||||
|
Expense ratio
|
37.7
|
34.4
|
||||||
|
Combined ratio
|
100.8
|
%
|
99.2
|
%
|
||||
|
|
Year Ended December 31,
|
|||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Medicare supplement
|
$
|
71,867
|
$
|
77,424
|
||||
|
Group life
|
14,700
|
12,431
|
||||||
|
Individual life
|
5,594
|
6,153
|
||||||
|
Group accident and health
|
11,390
|
7,583
|
||||||
|
Other individual health
|
7,491
|
6,791
|
||||||
|
Total
|
$
|
111,042
|
$
|
110,382
|
||||
| Item 7A. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 8. |
Financial Statements and Supplementary Data
|
| • |
Involving our actuarial specialists to assist in our procedures in:
|
| o |
Evaluating the appropriateness of management’s actuarial reserving methodologies and assumptions;
|
| o |
Evaluating management’s hindsight analyses;
|
| o |
Comparing management’s carried reserve to the range calculated by management’s specialist for property casualty claim reserves;
|
| • |
Testing the completeness and accuracy of data provided by management that served as the basis for the actuarial analyses on a sample basis; and
|
| • |
Evaluating movement of the Company’s recorded property casualty claim reserves within the Company’s estimated reserve range year over year.
|
| • |
Involving our actuarial specialists to assist in our procedures in:
|
| o |
Evaluating whether the methodology applied by management is consistent in the aggregate with the methodology compliant with US GAAP;
|
| o |
Assessing the significant assumptions used by management for new insurance contracts issued during the current year by comparing the significant assumptions noted
above to historical experience, observable market data or management’s estimates of prospective changes to these assumptions;
|
| o |
Reviewing benefit reserve replication workbooks prepared by management for a sample of contracts; and
|
| o |
Evaluating management’s loss recognition testing of aggregate reserve sufficiency.
|
| • |
Testing the completeness and accuracy of data used by management in developing assumptions on a sample basis.
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands,
except share and per
share data)
|
||||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Investments:
|
||||||||
|
Fixed maturities, available-for-sale, at fair value (amortized cost: $
|
|
|
||||||
|
Equity securities, at fair value (cost: $
|
|
|
||||||
|
Other invested assets (cost: $
|
|
|
||||||
|
Policy loans
|
|
|
||||||
|
Real estate
|
|
|
||||||
|
Investment in unconsolidated trusts
|
|
|
||||||
|
Total investments
|
|
|
||||||
|
Receivables:
|
||||||||
|
Reinsurance (net of allowance for uncollectible reinsurance of $
|
|
|
||||||
|
Insurance premiums and other (net of allowance for expected credit losses $
|
|
|
||||||
|
Deferred income taxes, net
|
|
|
||||||
|
Deferred acquisition costs
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Intangibles
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
|
Insurance reserves and policyholder funds
|
||||||||
|
Future policy benefits
|
$
|
|
$
|
|
||||
|
Unearned premiums
|
|
|
||||||
|
Losses and claims
|
|
|
||||||
|
Other policy liabilities
|
|
|
||||||
|
Total insurance reserves and policyholder funds
|
|
|
||||||
|
Accounts payable and accrued expenses
|
|
|
||||||
|
Revolving credit facility
|
||||||||
|
Junior subordinated debenture obligations, net
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
| Commitments and contingencies (Note 18) | ||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Common stock, $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Unearned stock grant compensation
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock, at cost,
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands,
except per share data)
|
||||||||
|
Revenue:
|
||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
||||
|
Net investment income
|
|
|
||||||
|
Realized investment gains, net
|
|
|
||||||
|
Unrealized losses on equity securities, net
|
(
|
)
|
(
|
)
|
||||
|
Other income
|
|
|
||||||
|
Total revenue
|
|
|
||||||
|
Benefits and expenses:
|
||||||||
|
Insurance benefits and losses incurred
|
|
|
||||||
|
Commissions and underwriting expenses
|
|
|
||||||
|
Interest expense
|
|
|
||||||
|
Other expense
|
|
|
||||||
|
Total benefits and expenses
|
|
|
||||||
|
Loss before income taxes
|
(
|
)
|
(
|
)
|
||||
|
Income tax benefit
|
(
|
)
|
(
|
)
|
||||
|
Net loss
|
(
|
)
|
(
|
)
|
||||
|
Preferred stock dividends
|
(
|
)
|
(
|
)
|
||||
|
Net loss applicable to common shareholders
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Loss per common share (basic and diluted)
|
(
|
)
|
(
|
)
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Other comprehensive gain (loss):
|
||||||||
|
Available-for-sale fixed maturity securities:
|
||||||||
|
Gross unrealized holding gain (loss) arising in the period
|
(
|
)
|
|
|||||
|
Related income tax effect
|
|
(
|
)
|
|||||
|
Subtotal
|
(
|
)
|
|
|||||
|
Less: reclassification adjustment for net realized gains included in net income
|
(
|
)
|
(
|
)
|
||||
|
Related income tax effect
|
|
|
||||||
|
Subtotal
|
(
|
)
|
(
|
)
|
||||
|
Total other comprehensive income (loss), net of tax
|
(
|
)
|
|
|||||
|
Total comprehensive income (loss)
|
$
|
(
|
)
|
$
|
|
|||
|
Year Ended December 31,
|
||||||||
|
(In thousands, except share and per share data)
|
2024
|
2023
|
||||||
|
Preferred stock:
|
||||||||
|
Balance, beginning of year
|
$
|
|
$
|
|
||||
|
Balance, end of year
|
|
|
||||||
|
Common stock:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Balance, end of year
|
|
|
||||||
|
Additional paid-in capital:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Balance, end of year
|
|
|
||||||
|
Retained earnings:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
|
( |
) | ||||||
|
Net loss
|
(
|
)
|
(
|
)
|
||||
|
Dividends on common stock
|
(
|
)
|
(
|
)
|
||||
|
Dividends accrued on preferred stock
|
(
|
)
|
(
|
)
|
||||
|
Balance, end of year
|
|
|
||||||
|
Accumulated other comprehensive loss:
|
||||||||
|
Balance, beginning of year
|
(
|
)
|
(
|
)
|
||||
|
Other comprehensive income (loss), net of tax
|
(
|
)
|
|
|||||
|
Balance, end of year
|
(
|
)
|
(
|
)
|
||||
|
Unearned stock grant compensation:
|
||||||||
|
Balance, beginning of year
|
(
|
)
|
(
|
)
|
||||
|
Amortization of unearned compensation
|
|
|
||||||
|
Balance, end of year
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock:
|
||||||||
|
Balance, beginning of year
|
(
|
)
|
(
|
)
|
||||
|
Net shares acquired related to employee share-based compensation plans
|
(
|
)
|
(
|
)
|
||||
|
Balance, end of year
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ equity
|
$
|
|
$
|
|
||||
|
Dividends declared on common stock per share
|
$
|
|
$
|
|
||||
|
Common shares outstanding:
|
||||||||
|
Balance, beginning of year
|
||||||||
|
Net shares acquired under employee share-based compensation plans
|
( |
) | ( |
) | ||||
|
Balance, end of year
|
||||||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Amortization of deferred acquisition costs
|
|
|
||||||
|
Acquisition costs deferred
|
(
|
)
|
(
|
)
|
||||
|
Realized investment gains, net
|
(
|
)
|
(
|
)
|
||||
|
Unrealized losses on equity securities, net
|
|
|
||||||
|
Losses from equity method investees
|
||||||||
|
Compensation expense related to share awards
|
|
|
||||||
|
(Benefit) provision for credit losses
|
( |
) | ||||||
|
Depreciation and amortization
|
|
|
||||||
|
Deferred income tax benefit
|
(
|
)
|
(
|
)
|
||||
|
Increase in receivables, net
|
(
|
)
|
(
|
)
|
||||
|
Increase in insurance reserves and policyholder funds
|
|
|
||||||
|
Increase (decrease) in accounts payable and accrued expenses
|
|
(
|
)
|
|||||
|
Other, net
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds from investments sold and policy loans redeemed
|
|
|
||||||
|
Proceeds from investments matured, called or redeemed
|
|
|
||||||
|
Investments purchased
|
(
|
)
|
(
|
)
|
||||
|
Additions to property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of dividends on Series D preferred stock
|
(
|
)
|
(
|
)
|
||||
|
Payment of dividends on common stock
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock acquired — net employee share-based compensation
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from revolving credit facility, net
|
||||||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Net increase (decrease) in cash
|
|
(
|
)
|
|||||
|
Cash and cash equivalents at beginning of year
|
|
|
||||||
|
Cash and cash equivalents at end of year
|
$
|
|
$
|
|
||||
|
Supplemental cash flow information:
|
||||||||
|
Cash paid for interest
|
$
|
|
$
|
|
||||
|
Cash paid for income taxes
|
$
|
|
$
|
|
||||
| Note 1. |
Summary of Significant Accounting Policies
|
| Note 2. |
Investments
|
| 2024 | ||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for
Credit
Losses
|
Amortized
Cost
|
||||||||||||||||
|
Fixed maturities:
|
||||||||||||||||||||
|
Bonds:
|
||||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||||
|
Loan backed and structured securities
|
||||||||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
||||||||||||||||
|
Corporate securities:
|
||||||||||||||||||||
|
Utilities and telecom
|
|
|
|
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||||||
|
Other business – diversified
|
|
|
|
|
||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
||||||||||||||||
|
Total corporate securities
|
|
|
|
|
||||||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
||||||||||||||||
|
Total redeemable preferred stocks
|
|
|
|
|
||||||||||||||||
|
Total fixed maturities
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||||
| 2023 |
||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for
Credit
Losses
|
Amortized
Cost
|
||||||||||||||||
|
Fixed maturities:
|
||||||||||||||||||||
|
Bonds:
|
||||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||||
|
Loan backed and structures securities
|
||||||||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
||||||||||||||||
|
Corporate securities:
|
||||||||||||||||||||
|
Utilities and telecom
|
|
|
|
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||||||
|
Other business – diversified
|
|
|
|
|
||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
||||||||||||||||
|
Total corporate securities
|
|
|
|
|
||||||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
||||||||||||||||
|
Total redeemable preferred stocks
|
|
|
|
|
||||||||||||||||
|
Total fixed maturities
|
$
|
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||||
|
2024
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||
|
Communications
|
|
|
|
|
||||||||||||
|
Total equity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2023
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||
|
Communications
|
|
|
|
|
||||||||||||
|
Total equity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2024
|
2023
|
|||||||||||||||
|
Carrying
Value
|
Amortized
Cost
|
Carrying
Value
|
Amortized
Cost
|
|||||||||||||
|
Due in one year or less
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Due after one year through five years
|
|
|
|
|
||||||||||||
|
Due after five years through ten years
|
|
|
|
|
||||||||||||
|
Due after ten years
|
|
|
|
|
||||||||||||
|
Asset backed securities
|
|
|
|
|
||||||||||||
|
Totals
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2024
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Loan backed and structured securities
|
||||||||||||||||||||||||
|
Obligations of states and political subdivisions
|
||||||||||||||||||||||||
|
Corporate securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Redeemable preferred stocks
|
||||||||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2023
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Loan backed and structured securities
|
||||||||||||||||||||||||
|
Obligations of states and political subdivisions
|
||||||||||||||||||||||||
|
Corporate securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2024
|
2023
|
|||||||
|
Fixed maturities
|
$
|
|
$
|
|
||||
|
Equity securities
|
|
|
||||||
|
Other
|
|
|
||||||
|
|
|
|||||||
|
Investment expenses
|
|
|
||||||
|
Net investment income
|
$
|
|
$
|
|
||||
| 2024 | ||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested Assets
|
Total | |||||||||||||
|
Gains
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Losses
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Realized investment gains, net
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| 2023 | ||||||||||||||||
|
Fixed
Maturities
|
Equity
Securities
|
Other
Invested Assets
|
Total | |||||||||||||
|
Gains
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Losses
|
|
|
|
|
||||||||||||
|
Realized investment gains, net
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2024
|
2023
|
|||||||
|
Sales proceeds
|
$
|
|
$
|
|
||||
|
Gross gains
|
|
|
||||||
|
Gross losses
|
|
|
||||||
|
2024
|
2023
|
|||||||
|
Sales proceeds
|
$
|
|
$
|
|
||||
|
Gross gains
|
|
|
||||||
|
Gross losses
|
|
|
||||||
|
2024
|
2023
|
|||||||
|
Sales proceeds
|
$
|
|
$
|
|
||||
|
Gross gains
|
|
|
||||||
|
Gross losses
|
|
|
|
|||||
|
2024
|
2023
|
|||||||
|
Net realized and unrealized losses recognized during the period on equity securities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Less: Net realized gains recognized during the period on equity securities sold during the period
|
|
|
||||||
|
Unrealized losses on equity securities, net
|
$
|
(
|
)
|
$
|
(
|
)
|
||
| Note 3. |
Disclosures About Fair Value of Financial Instruments
|
| Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria
include cash equivalents and exchange traded common stocks.
|
| Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its
fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In
determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers.
Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable
(e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.
|
| Level 3 |
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily
observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for
the asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of one equity security. As of December 31, 2024 and December 31, 2023, the value of the equity security valued using Level 3 criteria was $
|
|
Assets:
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
|
Fixed maturities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Equity securities
|
|
|
|
|
||||||||||||
|
Cash equivalents
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Assets:
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
||||||||||||
|
Fixed maturities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Equity securities
|
|
|
|
|
||||||||||||
|
Cash equivalents
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Level in
|
2024
|
2023
|
|||||||||||||||||
|
Fair Value
Hierarchy(1)
|
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
|||||||||||||||
|
Assets:
|
|||||||||||||||||||
|
Cash and cash equivalents
|
Level 1
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Fixed maturities
|
Level 2
|
|
|
|
|
||||||||||||||
|
Equity securities
|
(1) |
|
|
|
|
|
|||||||||||||
|
Policy loans
|
Level 3
|
|
|
|
|
||||||||||||||
|
Liabilities:
|
|||||||||||||||||||
|
Junior subordinated debentures, net
|
Level 2
|
|
|
|
|
||||||||||||||
|
Revolving credit facility
|
Level 2
|
||||||||||||||||||
| (1) |
|
| Note 4. |
Allowance for Expected Credit Losses
|
|
At and year ended December 31, 2024
|
||||||||
|
|
Reinsurance Recoverables,
Net of Allowance for
Expected Credit Losses
|
Allowance for Expected
Credit Losses
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
|
|
|||||||
|
Current period change for estimated uncollectible reinsurance
|
(
|
)
|
||||||
|
Write-offs of uncollectible reinsurance recoverables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
At and year ended December 31, 2023
|
||||||||
|
|
Reinsurance Recoverables,
Net of Allowance for
Expected Credit Losses
|
Allowance for Expected
Credit Losses
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
|
|
|||||||
|
Current period change for estimated uncollectible reinsurance
|
(
|
)
|
||||||
|
Write-offs of uncollectible reinsurance recoverables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
|
At and year ended December 31, 2024
|
|||||||
|
|
Insurance Premiums and
Other, Net of Expected
Credit Losses
|
Allowance for Expected
Credit Losses
|
||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Current period change for expected credit losses
|
(
|
)
|
||||||
|
Write-offs of uncollectible insurance premiums and other receivables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
At and year ended December 31, 2023
|
||||||||
|
Insurance Premiums and
Other, Net of Expected
Credit Losses
|
Allowance for Expected
Credit Losses
|
|||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023
|
|
|||||||
|
Current period change for expected credit losses
|
|
|||||||
|
Write-offs of uncollectible insurance premiums and other receivables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
| Note 5. |
Deferred Policy Acquisition Costs
|
| 2024 | 2023 |
|||||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
American
Southern
|
Bankers
Fidelity
|
|||||||||||||
|
Deferred policy acquisition costs:
|
||||||||||||||||
|
Balance, beginning of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Capitalization
|
|
|
|
|
||||||||||||
|
Amortization
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Balance, end of year
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| Note 6. | Internal-Use Software |
| Note 7. |
Insurance Reserves and Policyholder Funds
|
|
Amount of
Insurance In Force, Net
|
||||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
Future policy benefits
|
||||||||||||||||
|
Life insurance policies:
|
||||||||||||||||
|
Ordinary life and annuities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Group life
|
|
|
|
|
||||||||||||
|
|
|
$
|
|
$
|
|
|||||||||||
|
Accident and health insurance policies
|
|
|
||||||||||||||
|
|
|
|||||||||||||||
|
Unearned premiums
|
|
|
||||||||||||||
|
Losses, claims and loss adjustment expenses
|
|
|
||||||||||||||
|
Other policy liabilities
|
|
|
||||||||||||||
|
Total insurance reserves and policyholder funds
|
$
|
|
$
|
|
||||||||||||
|
2024
|
2023
|
|||||||
|
Balance at January 1
|
$
|
|
$
|
|
||||
|
Less: Reinsurance recoverable on unpaid losses
|
(
|
)
|
(
|
)
|
||||
|
Net balance at January 1
|
|
|
||||||
|
Incurred related to:
|
||||||||
|
Current year
|
|
|
||||||
|
Prior years
|
|
(1)
|
|
(2)
|
||||
|
Total incurred
|
|
|
||||||
|
Paid related to:
|
||||||||
|
Current year
|
|
|
||||||
|
Prior years
|
|
|
||||||
|
Total paid
|
|
|
||||||
|
Net balance at December 31
|
|
|
||||||
|
Plus: Reinsurance recoverable on unpaid losses
|
|
|
||||||
|
Balance at December 31
|
$
|
|
$
|
|
||||
| (1) |
|
| (2) |
|
|
2024
|
2023
|
|||||||
|
Total incurred losses
|
$
|
|
$
|
|
||||
|
Cash surrender value and matured endowments
|
|
|
||||||
|
Benefit reserve changes
|
|
|
||||||
|
Total insurance benefits and losses incurred
|
$
|
|
$
|
|
||||
|
For the Years Ended December 31,
|
As of December 31,
2024
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
IBNR
Reserves
|
Cumulative
Number of
Reported Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
As of December 31,
2024
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
As of December 31, 2024
|
|||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses,
Net of Reinsurance
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||
|
Accident Year
|
2020
|
2021
|
2022
|
2023
|
2024
|
|||||||||||||||||||||||
|
2020
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||
|
2021
|
|
|
|
|
|
|
||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|||||||||||||||||||||||
|
2023
|
|
|
|
|
||||||||||||||||||||||||
|
2024
|
|
|
|
|||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment
Expenses, Net of Reinsurance
|
||||||||||||||||||||
|
Accident Year
|
2020
|
2021
|
2022
|
2023
|
2024
|
|||||||||||||||
|
2020
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
2021
|
|
|
|
|
||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||
|
2023
|
|
|
||||||||||||||||||
|
2024
|
|
|||||||||||||||||||
|
$
|
|
|||||||||||||||||||
|
All outstanding liabilities before 2020, net of reinsurance
|
|
|
||||||||||||||||||
| Liabilities for losses, claims and loss adjustment expenses, net of reinsurance | $ |
|
||||||||||||||||||
|
For the Years Ended December 31,
|
As of December 31,
2024
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
All outstanding liabilities before 2015, net of reinsurance
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
As of December 31,
2024
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
||||||||||||||||||||||||||||||
|
2015
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2016
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
All outstanding liabilities before 2015, net of reinsurance
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Subrogation and Reinsurance (Unaudited)
|
||||||||||||||||||||||||||||||||||||||||
|
Reserve Line
|
1st Year
|
2nd Year
|
3rd Year
|
4th Year
|
5th Year
|
6th Year
|
7th Year
|
8th Year
|
9th Year
|
10th Year
|
||||||||||||||||||||||||||||||
|
Medicare Supplement
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Automobile Liability
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Automobile Physical Damage
|
|
%
|
|
%
|
|
%
|
|
%
|
-
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
General Liability
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Surety
|
|
%
|
|
%
|
|
%
|
|
%
|
-
|
%
|
-
|
%
|
-
|
%
|
|
%
|
-
|
%
|
|
%
|
||||||||||||||||||||
|
December 31, 2024
|
||||
|
Net outstanding liabilities
|
||||
|
Medicare supplement
|
$
|
|
||
|
Automobile liability
|
|
|||
|
Automobile physical damage
|
|
|||
|
General liability
|
|
|||
|
Surety
|
|
|||
|
Other short-duration insurance lines
|
|
|||
|
Liabilities for unpaid losses, claims and loss adjustment expenses, net of reinsurance
|
|
|||
|
Reinsurance recoverable on unpaid losses:
|
||||
|
Medicare supplement
|
|
|||
|
Automobile liability
|
|
|||
|
Automobile physical damage
|
|
|||
|
General liability
|
|
|||
|
Other short-duration insurance lines
|
||||
|
Total reinsurance recoverable on unpaid losses
|
|
|||
|
Unallocated claims adjustment expenses
|
|
|||
|
Total gross liability for unpaid losses, claims and loss adjustment expenses
|
$
|
|
||
| Note 8. |
Reinsurance
|
|
For the Year Ended December 31, 2024
|
||||||||||||
|
American
Southern |
Bankers
Fidelity
|
Total
|
||||||||||
|
Direct premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums written
|
|
|
|
|||||||||
|
Ceded premiums written
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Direct premiums earned
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums earned
|
|
|
|
|||||||||
|
Ceded premiums earned
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net premiums earned
|
$
|
|
$
|
|
$
|
|
||||||
|
Provision for benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
||||||
|
Reinsurance loss recoveries
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Insurance benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
||||||
|
For the Year Ended December 31, 2023
|
||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
||||||||||
|
Direct premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums written
|
|
|
|
|||||||||
|
Ceded premiums written
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Direct premiums earned
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums earned
|
|
|
|
|||||||||
|
Ceded premiums earned
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net premiums earned
|
$
|
|
$
|
|
$
|
|
||||||
|
Provision for benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
||||||
|
Reinsurance loss recoveries
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Insurance benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31, 2024
|
||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
||||||||||
|
Recoverable on unpaid losses, net of allowance
|
$
|
|
$
|
|
$
|
|
||||||
|
Recoverable on unpaid benefits
|
|
|
|
|||||||||
|
Recoverable on paid losses
|
|
|
|
|||||||||
|
Ceded unearned premiums
|
|
|
|
|||||||||
|
Ceded advanced premiums
|
|
|
|
|||||||||
|
Total reinsurance receivables
|
$
|
|
$
|
|
$
|
|
||||||
| December 31, 2023 | ||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
||||||||||
|
Recoverable on unpaid losses, net of allowance
|
$
|
|
$
|
|
$
|
|
||||||
|
Recoverable on unpaid benefits
|
|
|
|
|||||||||
|
Recoverable on paid losses
|
|
|
|
|||||||||
|
Ceded unearned premiums
|
|
|
|
|||||||||
|
Ceded advanced premiums
|
|
|
|
|||||||||
|
Total reinsurance receivables
|
$
|
|
$
|
|
$
|
|
||||||
| Note 9. |
Income Taxes
|
|
2024
|
2023
|
|||||||
|
Total tax benefit on income
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Tax expense (benefit) on components of shareholders’ equity:
|
||||||||
|
Net unrealized income (losses) on investment securities
|
(
|
)
|
|
|||||
|
Total tax expense (benefit)
|
$
|
(
|
)
|
$
|
|
|||
|
2024
|
2023
|
|||||||
|
Federal income tax provision at the statutory rate
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Statutory rate
|
|
%
|
|
%
|
||||
|
Dividends-received deduction
|
(
|
)
|
(
|
)
|
||||
|
Meals and entertainment
|
|
|
||||||
|
Vested stock and club dues
|
|
|
||||||
|
Parking disallowance
|
|
|
||||||
|
Adjustment for prior years’ estimates to actual
|
|
(
|
)
|
|||||
|
Income tax benefit
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Effective tax rate
|
|
%
|
|
%
|
||||
|
2024
|
2023
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Deferred acquisition costs
|
$
|
|
$
|
|
||||
|
Net unrealized investment losses
|
||||||||
|
Insurance reserves
|
|
|
||||||
|
Impaired assets
|
|
|
||||||
|
Bad debts and other
|
|
|
||||||
|
Net operating loss
|
||||||||
|
Total deferred tax assets
|
|
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Deferred and uncollected premiums
|
$
|
(
|
)
|
|
(
|
)
|
||
|
Total deferred tax liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net deferred tax asset
|
$
|
|
$
|
|
||||
|
2024
|
2023
|
|||||||
|
Current – Federal
|
$
|
|
$
|
|
||||
|
Deferred – Federal
|
(
|
)
|
(
|
)
|
||||
|
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
||
| Note 10. |
Credit Arrangements
|
|
Atlantic American
Statutory Trust I
|
Atlantic American
Statutory Trust II
|
|||||||
|
JUNIOR SUBORDINATED DEBENTURES(1)(2)
|
||||||||
|
Balance December 31, 2024
|
$
|
|
$ | |||||
|
Less: Treasury debt(3)
|
|
( |
) | |||||
|
Net balance December 31, 2024
|
$
|
|
$
|
|
||||
|
Net balance December 31, 2023
|
$
|
|
$
|
|
||||
|
Coupon rate
|
|
|||||||
|
Interest payable
|
||||||||
|
Maturity date
|
||||||||
|
Redeemable by issuer
|
||||||||
|
TRUST PREFERRED SECURITIES
|
||||||||
|
Issuance date
|
||||||||
|
Securities issued
|
|
|||||||
|
Liquidation preference per security
|
$
|
|
$
|
|
||||
|
Liquidation value
|
$
|
|
$
|
|
||||
|
Coupon rate
|
|
|||||||
|
Distribution payable
|
||||||||
|
Distribution guaranteed by(4)
|
|
|||||||
| (1) |
|
| (2) |
|
| (3) |
|
| (4) |
|
|
Note 11.
|
Leases
|
|
Year Ended
December 31, 2024
|
Year Ended
December 31, 2023
|
|||||||
|
Other information on operating leases:
|
||||||||
|
Cash payments included in the measurement of lease liabilities reported in operating cash flows
|
$
|
|
|
|||||
|
Right-of-use assets included in on the consolidated
balance sheet
|
|
|
||||||
|
Weighted average discount rate
|
|
%
|
|
%
|
||||
|
Weighted average remaining lease term in years
|
||||||||
|
Lease Liability
|
||||
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
| 2028 |
||||
| 2029 |
||||
|
Thereafter
|
|
|||
|
Total undiscounted lease payments
|
|
|||
|
Less: present value adjustment
|
|
|||
|
Operating lease liability included in
on the consolidated balance sheet
|
$
|
|
||
| Note 12. |
Benefit Plans
|
| Note 13. |
Preferred Stock
|
| Note 14. |
Loss Per Common Share
|
| For the Year Ended December 31, 2024 | ||||||||||||
| Loss |
Weighted
Average Shares
Outstanding
(In thousands)
|
Per Share
Amount
|
||||||||||
|
Basic and Diluted Loss Per Common Share
|
||||||||||||
|
Net loss before preferred stock dividends
|
$
|
(
|
)
|
|
-
|
|||||||
|
Less preferred stock dividends
|
(
|
)
|
—
|
|||||||||
|
Net loss applicable to common shareholders
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|||||
|
For the Year Ended December 31, 2023
|
||||||||||||
|
Loss
|
Weighted
Average Shares
Outstanding
(In thousands)
|
Per Share
Amount
|
||||||||||
|
Basic and Diluted Loss Per Common Share
|
||||||||||||
|
Net loss before preferred stock dividends
|
$
|
(
|
)
|
|
-
|
|||||||
|
Less preferred stock dividends
|
(
|
)
|
—
|
|||||||||
|
Net loss applicable to common shareholders
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|||||
| Note 15. |
Statutory Reporting
|
|
2024
|
2023
|
|||||||
|
Bankers Fidelity, net income
|
$
|
|
$
|
|
||||
|
American Southern, net income
|
|
|
||||||
|
Statutory net income
|
$
|
|
$
|
|
||||
|
Bankers Fidelity, capital and surplus
|
$
|
|
$
|
|
||||
|
American Southern, capital and surplus
|
|
|
||||||
|
Statutory capital and surplus
|
$
|
|
$
|
|
||||
| Note 16. |
Related Party Transactions
|
| Note 17. |
Segment Information
|
|
For the Year Ended December 31, 2024
|
||||||||||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Corporate
& Other
|
Adjustments
& Eliminations
|
Consolidated
|
||||||||||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Insurance benefits and losses incurred
|
|
|
|
|
|
|||||||||||||||
|
Expenses deferred
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||
|
Amortization and depreciation expense
|
|
|
|
|
|
|||||||||||||||
|
Other expenses
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Total expenses
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Underwriting income
|
(
|
)
|
(
|
)
|
|
( |
) | |||||||||||||
|
Net investment income (loss)
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Other income (loss)
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Subtotal
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
|
Net realized gains
|
|
|
|
|
|
|||||||||||||||
|
Unrealized losses on equity securities
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Income (loss) before income taxes
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
|
Intangibles
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
|
For the Year Ended December 31, 2023
|
||||||||||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Corporate
& Other
|
Adjustments
& Eliminations
|
Consolidated
|
||||||||||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Insurance benefits and losses incurred
|
|
|
|
|
|
|||||||||||||||
|
Expenses deferred
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||
|
Amortization and depreciation expense
|
|
|
|
|
|
|||||||||||||||
|
Other expenses
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Total expenses
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Underwriting income
|
|
|
|
|||||||||||||||||
|
Net investment income (loss)
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Other income (loss)
|
|
|
|
(
|
)
|
|
||||||||||||||
|
Subtotal
|
|
|
(
|
)
|
|
|
||||||||||||||
|
Net realized gains (losses)
|
|
|
|
|
|
|||||||||||||||
|
Unrealized losses on equity securities
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Income (loss) before income taxes
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
|
Intangibles
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
| Note 18. |
Commitments and Contingencies
|
| Note 19. |
Subsequent Events
|
| Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
| Item 9A. |
Controls and Procedures
|
| Item 9B. |
Other Information
|
| Item 9C. |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
|
|
Plan Category
|
Number of
Securities to Be
Issued Upon
Exercise of
Outstanding
Options,
Warrants
and Rights
|
Weighted-Average
Exercise Price
of Outstanding
Options,
Warrants
and Rights
|
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in the
First Column)
|
|||||||||
|
Equity compensation plans approved by security holders
|
—
|
$
|
—
|
2,960,000
|
||||||||
|
Equity compensation plans not approved by security holders(1)
|
—
|
—
|
—
|
|||||||||
|
Total
|
—
|
$
|
—
|
2,960,000
|
||||||||
| (1) |
All of the Company’s equity compensation plans have been approved by the Company’s shareholders.
|
| Item 15. |
Exhibits and Financial Statement Schedules
|
| (a) |
List of documents filed as part of this report:
|
| 1. |
Financial Statements:
|
| 2. |
Financial Statement Schedules:
|
| 3. |
Exhibits *:
|
|
Restated Articles of Incorporation of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 10-K for the year ended December 31, 2008].
|
||
|
Restated Bylaws of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed on March 4, 2016].
|
||
|
Description of the registrant’s common stock registered pursuant to section 12 of the Securities Exchange Act of 1934 [incorporated by reference to Exhibit 4.1 to the registrant’s Form
10-K filed on March 24, 2020].
|
||
|
10.01
|
Management Agreement, dated July 1, 1993, between the registrant and Atlantic American Life Insurance Company and Bankers Fidelity Life Insurance Company [incorporated by reference to
Exhibit 10.41 to the registrant’s Form 10-Q for the quarter ended September 30, 1993].
|
|
|
Tax Allocation Agreement, dated as of January 4, 2016, between the registrant and the registrant’s subsidiaries [incorporated by reference to Exhibit 10.02 to the registrant’s Form
10-K for the year ended December 31, 2017].
|
||
|
Atlantic American Corporation 2012 Nonqualified Stock Purchase Plan [incorporated by reference to Exhibit 99.1 to the registrant’s Form S-8 (File No. 333-183207) filed on August 10,
2012].
|
||
|
Atlantic American Corporation 2012 Equity Incentive Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 10-Q for the quarter ended March 31, 2013].
|
||
|
Lease Agreement, dated as of November 1, 2007, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life
Insurance Company [incorporated by reference to Exhibit 10.10 to the registrant’s Form 10-K for the year ended December 31, 2007].
|
||
|
First Amendment to Lease Agreement, dated as of March 31, 2008, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation
and Delta Life Insurance Company [incorporated by reference to Exhibit 10.2 to the registrant’s Form 10-Q for the quarter ended March 31, 2008].
|
||
|
Assignment and Assumption of Leases and Contracts, dated as of December 21, 2022, by and between Delta Life Insurance Company and 4370 Peachtree LLC [incorporated by reference to
Exhibit 10.07 to the registrant’s Form 10-K filed on June 30, 2023].
|
||
|
Revolving Credit Agreement, dated as of May 12, 2021, as amended by that certain First Amendment to Revolving Credit Agreement, dated as of March 22, 2024, by and between Atlantic
American Corporation and Truist Bank [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed with the SEC on May 13, 2021].
|
||
|
Atlantic American Corporation 2022 Equity and Incentive Compensation Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed on May 31, 2022].
|
||
|
Second Amendment to Lease Agreement, dated as of December 26, 2024, by and among 4370 Peachtree LLC, Atlantic American Corporation and Bankers Fidelity Life Insurance Company
[incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed with the SEC on December 30, 2024].
|
||
|
Code of Business Conduct and Ethics [incorporated by reference to Exhibit 14.1 to the registrant’s Form 10-K for the year ended December 31, 2003].
|
||
| 19.1 |
Atlantic
American Corporation Insider Trading Policy
|
|
|
Subsidiaries of the registrant [incorporated by reference to Exhibit 21.1 to the registrant’s Form 10-K for the year ended December 31, 2015].
|
||
|
Consent of Forvis Mazars, LLP, Independent Registered Public Accounting Firm.
|
||
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
Atlantic American Corporation Compensation Clawback Policy
|
||
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.
|
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase.
|
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase.
|
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase.
|
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase.
|
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
| * |
The registrant agrees to furnish to the Commission upon request a copy of any instruments defining the rights of security holders of the registrant that may be omitted from filing in accordance with the
Commission’s rules and regulations.
|
| ** |
Management contract, compensatory plan or arrangement.
|
| Item 16. |
Form 10-K Summary
|
|
ATLANTIC AMERICAN CORPORATION
|
||
|
(Registrant)
|
||
|
By:
|
/s/ J. Ross Franklin
|
|
|
J. Ross Franklin
|
||
|
Vice President and Chief Financial Officer
|
||
|
Date: March 25, 2025
|
|
Signature
|
Title
|
Date
|
||
|
/s/ Hilton H. Howell, Jr.
|
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
March 25, 2025
|
||
|
HILTON H. HOWELL, JR.
|
||||
|
/s/ J. Ross Franklin
|
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
March 25, 2025
|
||
|
J. ROSS FRANKLIN
|
||||
|
/s/ Robin R. Howell
|
Director
|
March 25, 2025
|
||
|
ROBIN R. HOWELL
|
||||
|
/s/ Mark E. Preisinger
|
Director
|
March 25, 2025
|
||
|
MARK E. PREISINGER
|
||||
|
/s/ Joseph M. Scheerer
|
Director
|
March 25, 2025
|
||
|
JOSEPH M. SCHEERER
|
||||
|
/s/ Scott G. Thompson
|
Director
|
March 25, 2025
|
||
|
SCOTT G. THOMPSON
|
||||
|
/s/ D. Keehln Wheeler
|
Director
|
March 25, 2025
|
||
|
D. KEEHLN WHEELER
|
|
December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Investments
|
|
|
||||||
|
Investment in subsidiaries
|
|
|
||||||
|
Investments in unconsolidated trusts
|
|
|
||||||
| Deferred tax asset, net | ||||||||
|
Income taxes receivable from subsidiaries
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Other payables
|
$ |
$ |
||||||
|
Revolving credit facility
|
||||||||
|
Junior subordinated debentures obligations, net
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Revenue
|
||||||||
|
Fee income from subsidiaries
|
$
|
|
$
|
|
||||
|
Distributed earnings from subsidiaries
|
|
|
||||||
|
Unrealized losses on equity securities, net
|
(
|
)
|
(
|
)
|
||||
|
Other
|
(
|
)
|
(
|
)
|
||||
|
Total revenue
|
|
|
||||||
|
General and administrative expenses
|
|
|
||||||
|
Interest expense
|
|
|
||||||
|
(
|
)
|
(
|
)
|
|||||
|
Income tax benefit(1)
|
(
|
)
|
(
|
)
|
||||
|
|
|
|||||||
|
Equity in undistributed earnings of subsidiaries, net
|
(
|
)
|
(
|
)
|
||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
| (1) |
|
|
Year Ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
(In thousands)
|
||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Unrealized losses on equity securities, net
|
|
|
||||||
|
Depreciation and amortization
|
|
|
||||||
|
Compensation expense related to share awards
|
|
|
||||||
|
Loss from equity method investees
|
||||||||
|
Equity in undistributed earnings of subsidiaries, net
|
|
|
||||||
|
Decrease (increase) in intercompany taxes
|
|
(
|
)
|
|||||
|
Deferred income tax benefit
|
(
|
)
|
(
|
)
|
||||
|
Increase (decrease) in accounts payable and accrued expenses
|
|
(
|
)
|
|||||
|
Other, net
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of dividends on Series D preferred stock
|
(
|
)
|
(
|
)
|
||||
|
Payment of dividends on common stock
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from revolving credit facility, net
|
||||||||
|
Treasury stock acquired — net employee share-based compensation
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Net increase in cash
|
|
|
||||||
|
Cash and cash equivalents at beginning of year
|
|
|
||||||
|
Cash and cash equivalents at end of year
|
$
|
|
$
|
|
||||
|
Supplemental disclosure:
|
||||||||
|
Cash paid for interest
|
$
|
|
$
|
|
||||
|
Cash paid for income taxes
|
$
|
|
$
|
|
||||
|
Intercompany tax settlement from subsidiaries
|
$
|
|
$
|
|
||||
|
Segment
|
Deferred
Acquisition
Costs
|
Future Policy
Benefits,
Losses,
Claims and
Loss
Reserves
|
Unearned
Premiums
|
Other Policy
Claims and
Benefits
Payable
|
||||||||||||
|
(In thousands)
|
||||||||||||||||
|
December 31, 2024:
|
||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
American Southern
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
(1)
|
$
|
|
$
|
|
||||||||
|
December 31, 2023:
|
||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
American Southern
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
(2)
|
$
|
|
$
|
|
||||||||
| (1) |
|
| (2) |
|
|
Segment
|
Premium
Revenue
|
Net
Investment
Income
|
Benefits,
Claims,
Losses and
Settlement
Expenses
|
Amortization
of Deferred
Acquisition
Costs
|
Other
Operating
Expenses
|
Casualty
Premiums
Written
|
||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||
|
December 31, 2024:
|
||||||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
American Southern
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate & other
|
|
|
|
|
|
|
||||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
|
December 31, 2023:
|
||||||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
American Southern
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate & other
|
|
(
|
)
|
|
|
|
|
|||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
|
Direct
Amount
|
Ceded to
Other
Companies
|
Assumed
From Other
Companies
|
Net
Amounts
|
Percentage
of Amount
Assumed
to Net
|
||||||||||||||||
|
(Dollars in thousands)
|
||||||||||||||||||||
|
Year ended December 31, 2024:
|
||||||||||||||||||||
|
Life insurance in force
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Premiums —
|
||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
American Southern
|
|
(
|
)
|
|
|
|
%
|
|||||||||||||
|
Total premiums
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
Year ended December 31, 2023:
|
||||||||||||||||||||
|
Life insurance in force
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
Premiums —
|
||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
American Southern
|
|
(
|
)
|
|
|
|
%
|
|||||||||||||
|
Total premiums
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
Claims and Claim
Adjustment
Expenses Incurred
Related To
|
||||||||||||||||||||||||||||||||||||||||
|
Year Ended
|
Deferred
Policy
Acquisition
Costs
|
Reserves
|
Unearned
Premiums
|
Earned
Premiums
|
Net
Investment
Income
|
Current
Year
|
Prior
Years
|
Amortization
of Deferred
Acquisition
Costs
|
Paid Claims
and Claim
Adjustment
Expenses
|
Premiums
Written
|
||||||||||||||||||||||||||||||
|
|
(In thousands) | |||||||||||||||||||||||||||||||||||||||
|
December 31, 2024
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
December 31, 2023
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
| 1. |
The following sentence is added after the first sentence in Section 3 (entitled Rent) of the Lease:
|
| 2. |
Section 4 (entitled Rent Adjustment) in the Lease is deleted and replaced with the following:
|
| 3. |
The terms and provisions of the Lease, as amended hereby, shall be construed, and enforced in accordance with the laws of the State of Georgia. Signatures transmitted by email or digital signatures will be deemed, and will have the same
legal force and effect as, an original. A photographic copy of the Lease and any amendments thereto (which are signed by the parties) will be effective as an original. Except as set forth in this Second Amendment, the Lease will continue
in full force and effect. In the event of a conflict between this Second Amendment and the Lease, this Second Amendment will prevail.
|
|
Lessor: 4370 PEACHTREE LLC
|
Lessee: ATLANTIC AMERICAN CORPORATION
|
|
By: /s/ Julie M. Myrick
|
By: /s/ J. Ross Franklin
|
|
Name: Julie M Wyrick
|
Name: J. Ross Franklin
|
|
Title: Manager
|
Title: Chief Financial Officer
|
|
Lessee: BANKERS FIDELITY LIFE INSURANCE COMPANY
|
|
|
By: /s/ C. McClure King
|
|
|
Name: C. McClure King
|
|
| Title: President |

| (a) |
Members of Atlantic American’s Board of Directors (the “Board”);
|
| (b) |
“Executive Officers” of Atlantic American as designated by the Board for purposes of Rule 3b-7 under the Securities Exchange Act of 1934 (the “Exchange
Act”) and identified under Item 401(b) of Regulation S-K and any other officers from time to time determined to be subject to the reporting requirements of Section 16 (“Section 16”) of the Exchange Act;
|
| (c) |
Designated Atlantic American employees as may be identified from time to time by Atlantic American’s executive officers; and
|
| (d) |
All family members of the Preclearance Group. The general definition of family members includes any child, step-child, grandchild, parent, step-parent,
grandparent, spouse, sibling, father-in-law, mother-in-law, son-in-law, daughter-in-law, brother-in-law, sister-in-law, and any adoptive relationships, where such family member is living in the same household with a member of the Preclearance
Group or a member of the Preclearance Group has voting power or dispositive power over company stock held in the name of or for the benefit of the family member.
|
| (a) |
The Preclearance Group may not trade in Atlantic American’s securities (other than as specified by this Policy) (i) during the period beginning on the
day that is fourteen (14) calendar days prior to the end of any fiscal quarter or fiscal year end and ending at the start of the second full trading day following the public announcement of the Company’s earnings for that fiscal period by
Atlantic American or (ii) during any other “blackout period” as designated by the Company’s Vice President, Chief Financial Officer and Secretary.
|
| (b) |
The blackout period trading prohibition applies to all transactions involving Atlantic American securities.
|
| (c) |
Note that at all times, the Preclearance Group remains subject to the prohibition against trading on the basis of material nonpublic information during
periods outside of the blackout periods.
|
| (d) |
The Preclearance Group may only trade in Atlantic American securities on an occasional basis consistent with an investment strategy such as not to
appear to be speculating in the Company’s securities or engaging in day trading.
|
| (e) |
The Preclearance Group must not engage in short selling of or trading in puts and calls in respect of Atlantic American securities or any other hedging
strategies.
|
| (a) |
Prior to commencing any transaction in the Company’s securities, each member of the Preclearance Group must contact the Vice President, Chief Financial
Officer and Secretary (or such other officer of the Company as may be designated by the Board of Directors, the “Clearance Agent”) to seek authorization to proceed. Such authorization request to the Clearance Agent must be in writing and must
include the date of the proposed transaction, the nature of the transaction (purchase, sale, gift or other stock related transaction), the number of shares of the Company’s securities to be involved or the approximate value of the
transaction.
|
| (b) |
The Clearance Agent will consider the request and respond in writing to the requesting party within two business days of receiving the request. Such
response shall be a written authorization or denial of the requesting party’s proposed transaction.
|
| (a) |
Restricted Stock Awards – The acquisition of
shares of common stock upon vesting or granting of restricted stock or other stock awards or the exercise of a tax withholding right pursuant to which the Company withholds shares of stock to satisfy tax withholding requirements upon the
vesting of any restricted stock or other stock awards; however, this exception does not include the subsequent sale of the shares acquired upon vesting of restricted stock or other stock awards;
|
| (b) |
Stock Option Exercises – Exercises of stock
options for cash granted under the Company’s equity compensation plans; however, this exception does not include the subsequent sale of the shares acquired pursuant to the exercise of a stock option;
|
| (c) |
Bona Fide Gifts – Bona fide gifts of securities
shall be deemed to be an exempt transaction for the purposes of this Policy. However, during any blackout period, the Preclearance Group must preclear all bona fide gifts of securities with the Clearance Agent. Whether a gift is truly bona
fide will depend on the circumstances surrounding the specific gift. The more unrelated the donee is to the donor, the more likely the gift would be considered “bona fide” and not a “transaction.” For example, gifts to charities, churches or
non-profit organizations generally are not deemed to be “transactions.” However, gifts to dependent children followed by the sale of the gifted stock in close proximity to the time of the gift may imply some economic benefit to the donor and,
therefore, may be deemed to be a non-exempt transaction and not a bona fide gift;
|
| (d) |
10b5-1 Plan Transactions – Transactions pursuant
to a previously established contract, plan or instruction to trade in Atlantic American’s securities (a “10b5-1 Plan”) entered in accordance with Rule 10b5-1 under the Exchange Act, and approved by the Clearance Agent;
|
| (e) |
Domestic Relations Order – Any acquisition or
disposition of Atlantic American securities pursuant to a domestic relations order, as defined in the Internal Revenue Code or Title I of the Employee Retirement Income Security Act, shall be deemed to be an exempt transaction for the
purposes of this Policy; and
|
| (f) |
Other Transactions – Any other purchase of
Company Securities from the Company or sales of Company Securities to the Company.
|
|
|
|
| Employee Signature |
|
|
|
|
| Print Employee Name |
|
|
|
|
| Job Title |
|
|
|
|
| Date |
| 1. |
I have reviewed this annual report on Form 10-K of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b) |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant’s ability to record, process, summarize and report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
|
|
Date: March 25, 2025
|
/s/ Hilton H. Howell, Jr.
|
||
|
Hilton H. Howell, Jr.
|
|||
|
President and Chief Executive Officer
|
| 1. |
I have reviewed this annual report on Form 10-K of Atlantic American Corporation;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
| 4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
| a) |
designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
|
| b) |
designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
|
| c) |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
| d) |
disclosed in this report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
|
| 5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
|
| a) |
all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
| b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
|
|
Date: March 25, 2025
|
/s/ J. Ross Franklin
|
||
|
J. Ross Franklin
|
|||
|
Vice President and
|
|||
|
Chief Financial Officer
|
| (1) |
The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
|
| (2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates
and for the periods expressed in the Report.
|
|
Date: March 25, 2025
|
/s/ Hilton H. Howell, Jr.
|
||
|
Hilton H. Howell, Jr.
|
|||
|
President and Chief Executive Officer
|
|||
|
Date: March 25, 2025
|
/s/ J. Ross Franklin
|
||
|
J. Ross Franklin
|
|||
|
Vice President and Chief Financial Officer
|
| • |
“Covered Compensation” is defined as the
amount of Incentive-Based Compensation (as defined below) Received during the applicable Recovery Period (as defined below) that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received during such Recovery
Period had it been determined based on the relevant restated amounts, and computed without regard to any taxes paid.
|
| • |
“Incentive-Based Compensation” is defined
as any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure (as defined below). For purposes of clarity, Incentive-Based Compensation includes compensation that is in
any plan, other than tax-qualified retirement plans, including long term disability, life insurance, and supplemental executive retirement plans, and any other compensation that is based on such Incentive-Based Compensation, such as
earnings accrued on notional amounts of Incentive-Based Compensation contributed to such plans.
|
| • |
“Financial Reporting Measure” is defined as
a measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total
shareholder return are also Financial Reporting Measures.
|
| • |
Incentive-Based Compensation is deemed “Received”
in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that
period.
|
| • |
the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered (and the Company has already made a reasonable
attempt to recover such erroneously awarded Covered Compensation from such Covered Officer, has documented such reasonable attempt(s) to recover, and has provided such documentation to the Stock Exchange);
|
| • |
recovery would violate home country law that was adopted prior to November 28, 2022 (and the Company has already obtained an opinion of home country counsel,
acceptable to the Stock Exchange, that recovery would result in such a violation, and provided such opinion to the Stock Exchange); or
|
| • |
recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the
requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code and regulations thereunder. For purposes of clarity, this Clawback Exception only applies to tax-qualified retirement plans and does not apply to other plans,
including long term disability, life insurance, and supplemental executive retirement plans, or any other compensation that is based on Incentive-Based Compensation in such plans, such as earnings accrued on notional amounts of
Incentive-Based Compensation contributed to such plans.
|
| • |
acknowledges that he or she has been designated as (or assumed the position of) a “Covered Officer” as defined in the Policy;
|
| • |
acknowledges and consents to the Policy;
|
| • |
acknowledges and consents to be bound by the terms of the Policy;
|
| • |
agrees to fully cooperate with the Company in connection with any of the undersigned’s obligations to the Company pursuant to the Policy; and
|
| • |
agrees that the Company may enforce its rights under the Policy through any and all reasonable means permitted under applicable law as the Company deems necessary or
desirable under the Policy.
|
|
ACKNOWLEDGED AND AGREED:
|
|
| ________________________________ | |
|
Name: [NAME]
|
|
| ________________________________ | |
|
|
Date: [DATE]
|